Culture, Lifestyle

Drug Use In Baseball: From Early Doping to Modern MLB

July 31, 2025 06:00 am ET Estimated Read Time: 13 Minutes

Fact checked by Precious Ileh

Drug Use In Baseball: From Early Doping to Modern MLB

Baseball has a complex relationship with drugs that spans over a century, from early amphetamine use and tobacco culture to the steroid era scandals and today’s evolving cannabis policies. This history reveals how pressure, performance demands, and changing medical understanding have shaped drug use across major league baseball.

The story of drugs in baseball isn’t just about performance enhancement. It encompasses recreational substances, pain management evolution, and the ongoing tension between competitive advantage and player health. Understanding this timeline helps explain how MLB’s current policies developed and where the sport might be heading.

Why Baseball Players Turn to Drugs: Pressure, Performance, and Pain

Major league baseball players face unique pressures that have driven drug use throughout the sport’s history. The combination of intense public scrutiny, career-threatening injuries, and the pursuit of record-breaking performance creates conditions where players seek chemical assistance.

Financial pressure plays a central role in player decisions. With careers averaging less than six years and millions of dollars at stake, players often view performance-enhancing substances as career insurance. The difference between a successful season and a struggling one can determine whether a player secures a multi-year contract or faces minor league assignments.

The physical demands of a 162-game season compound these pressures. Baseball requires sustained focus and physical precision over eight months, creating fatigue that players have historically addressed through stimulants. From amphetamines in the 1960s to modern recovery protocols, the challenge of maintaining peak performance across an entire season remains constant.

Three primary factors drive drug use in baseball:

Performance pressure: The need to maintain statistics that determine contracts and career longevity
Pain management: Dealing with chronic injuries while continuing to play at the highest level
Mental focus: Sustaining concentration and confidence throughout grueling seasons and high-stakes situations

Early Drug Use in Baseball: The Foundation Years (1900-1970)

Baseball’s relationship with drugs began long before the steroid era captured headlines. During the early and mid-20th century, amphetamine use became normalized throughout major league baseball, with players openly sharing “greenies” to combat fatigue and maintain alertness during long seasons.

Amphetamines, originally developed for military use during World War II, found their way into baseball clubhouses by the 1950s. Players discovered these stimulants helped them stay sharp during day games after night games, leading to widespread adoption across teams. Hall of Famer Mike Schmidt later admitted that amphetamine use was so common that players who didn’t take them were at a disadvantage.

Tobacco culture dominated baseball from its earliest professional days. Players chewed tobacco and smoked cigarettes both on and off the field, with tobacco companies heavily sponsoring teams and individual players. This relationship continued well into the 1990s, creating generations of players addicted to nicotine while performing.

Alcohol presented another consistent challenge throughout baseball’s early decades. The sport’s social culture encouraged drinking, and many legendary players struggled with alcoholism. Unlike performance-enhancing drugs, alcohol typically hurt performance, but its social acceptance within baseball culture made it difficult to address systematically.

The lack of drug testing or formal policies during this era meant that substance use operated in an unregulated environment. What players took remained largely a matter of personal choice and clubhouse culture, setting the stage for more serious problems that would emerge in later decades.

The Pittsburgh Drug Trials: Baseball’s Cocaine Crisis (1985)

The Pittsburgh drug trials of 1985 exposed the most serious drug crisis in baseball history, revealing widespread cocaine use among major league players and forcing the sport to confront recreational drug abuse for the first time. The federal investigation centered on Curtis Strong, a Philadelphia caterer who sold cocaine to players from multiple teams.

Twenty-four players were called to testify during the trials, including stars like Keith Hernandez, Dave Parker, and Dale Berra. Their testimony revealed a cocaine network that extended across MLB, with players using the drug both recreationally and as a performance enhancer. The trials demonstrated how cocaine had infiltrated clubhouses throughout the 1970s and early 1980s.

The investigation uncovered disturbing details about cocaine’s role in baseball culture. Players testified about using cocaine before games, sharing it in clubhouses, and introducing teammates to dealers. The drug’s stimulant effects appealed to players seeking energy and confidence, but many developed serious addictions that affected their performance and personal lives.

Key outcomes from the Pittsburgh drug trials:

Seven players received one-year suspensions that were later reduced to community service and drug testing
Curtis Strong received a 12-year federal prison sentence for his role as the primary dealer
MLB implemented its first comprehensive drug policy in 1986, including testing and treatment programs
Public perception of baseball shifted as fans grappled with their heroes’ drug use
The trials sparked Congressional interest in sports drug use that would resurface during the steroid era

The Pittsburgh trials marked a turning point in baseball’s approach to drug use. The sport could no longer ignore recreational drug abuse, leading to policies that would evolve into today’s comprehensive testing programs. The scandal also demonstrated how drug use could threaten baseball’s family-friendly image and relationship with fans.

The Steroid Era: Baseball’s Biggest Scandal

The steroid era transformed baseball from the late 1980s through the early 2000s, creating the sport’s most controversial period and fundamentally changing how fans view statistical achievements. This era saw record-breaking performances that captivated audiences while hiding a systematic approach to performance enhancement that would eventually destroy careers and reputations.

The era began quietly in the late 1980s when weight training became more accepted in baseball culture. Players like Jose Canseco pioneered steroid use, achieving dramatic physical transformations that coincided with unprecedented power numbers. The lack of testing allowed steroid use to spread throughout MLB without consequences.

Home run records fell dramatically during the peak years. Mark McGwire and Sammy Sosa’s 1998 home run chase captivated America, with both players surpassing Roger Maris’s long-standing record of 61. Barry Bonds later set the single-season record with 73 home runs in 2001 and broke Hank Aaron’s all-time record in 2007, achievements now viewed skeptically due to steroid allegations.

Timeline of steroid era key events:

Year	Event	Impact
1988	Jose Canseco becomes first player to hit 40 HRs and steal 40 bases	Demonstrates new athletic possibilities
1998	McGwire-Sosa home run chase	Saves baseball after 1994 strike
2003	First MLB steroid testing begins	Survey testing reveals widespread use
2005	Congressional hearings on steroids	Public exposure of the problem
2007	Mitchell Report released	Names 89 players in comprehensive investigation

The era’s end came through mounting pressure from Congress, media investigations, and the Mitchell Report. Players like Barry Bonds, Roger Clemens, and Mark McGwire faced legal challenges and public scrutiny. The scandal tainted statistical achievements and raised questions about which records should stand, creating lasting divisions among fans about this period’s legacy.

MLB Drug Testing Evolution: From Voluntary to Mandatory

Major League Baseball’s drug testing program evolved from complete absence to comprehensive monitoring, driven by scandals and external pressure rather than proactive policy-making. The transformation from voluntary participation to mandatory year-round testing represents one of the most dramatic policy shifts in professional sports history.

The first voluntary testing program to determine steroid use scope emerged in 2003. When results showed that 5-7% of players tested positive, MLB implemented mandatory testing in 2004. The initial penalties were minimal, a counseling session for first offenses and 15-game suspensions for second offenses.

Congressional pressure intensified enforcement after high-profile hearings in 2005. Politicians threatened federal intervention if baseball didn’t strengthen its policies, leading to progressively harsher penalties. The program expanded beyond steroids to include amphetamines, HGH testing, and other performance-enhancing substances.

Current MLB drug testing policy includes:

Substance Category	Testing Frequency	First Offense	Second Offense	Third Offense
Performance-Enhancing Drugs	Random year-round	80 games	162 games	Lifetime ban
Amphetamines	Random year-round	Treatment program	25 games	80 games
Recreational Drugs	For cause only	Treatment program	25-50 games	50-100 games

The testing program now includes both announced and unannounced tests throughout the year, including the off-season. Players can be tested multiple times per year, and the biological passport system tracks individual baselines to detect subtle changes that might indicate drug use.

Modern testing faces new challenges with designer drugs and masking agents. The program continuously adapts to address emerging substances and methods, working with WADA-accredited laboratories to stay ahead of those seeking to circumvent detection.

Notable Drug Suspensions and Their Impact on the Game

High-profile drug suspensions have shaped public perception of baseball while demonstrating the real consequences of MLB’s evolving drug policies. These cases span multiple eras and substance categories, showing how enforcement has affected both individual careers and the sport’s broader culture.

The Alex Rodriguez suspension in 2014 marked the most significant punishment in baseball history. His 211-game suspension for connections to the Biogenesis clinic cost him an entire season and approximately $25 million in salary. The case showed MLB’s willingness to pursue complex investigations beyond simple positive tests.

Major suspension cases by category:

Steroid-related suspensions: Ryan Braun (65 games, 2013), Nelson Cruz (50 games, 2013), Jhonny Peralta (50 games, 2013)
Stimulant violations: Mike Cameron (25 games, 2008), J.C. Romero (50 games, 2009)
Recreational drug suspensions: Josh Hamilton (multiple suspensions for alcohol), Starling Marte (80 games, 2017 for Nandrolone)
HGH violations: Dee Gordon (80 games, 2016), Daniel Stumpf (80 games, 2019)

These suspensions demonstrate how drug policy enforcement affects team performance and individual careers. Players lose significant salary during suspensions, teams lose key contributors during crucial stretches, and fans lose trust in statistical achievements. The financial impact extends beyond player salaries to include lost endorsements and damaged reputations.

Recent suspensions show that drug use hasn’t disappeared despite comprehensive testing. Players continue seeking edges through new substances or methods, leading to an ongoing arms race between users and testing technology. Each high-profile case reinforces the policy’s deterrent effect while highlighting the continuing challenges.

Modern MLB and Cannabis: Policy Changes and Medical Applications

Cannabis represents the newest frontier in baseball’s drug policy evolution, with MLB taking a markedly different approach than it has with other substances. The league’s 2019 policy changes removed marijuana from the banned substance list for major league players, reflecting broader societal shifts toward cannabis acceptance and medical applications.

The policy change came after years of advocacy from players and growing recognition of cannabis’s potential medical marijuana applications. Unlike previous drug policy changes driven by scandal, cannabis reform emerged from medical research and player wellness initiatives rather than crisis response.

Current MLB cannabis policy creates different rules for different player levels. Major league players face no testing or penalties for marijuana use, while minor league players still face restrictions. This two-tiered approach reflects the sport’s cautious evolution on cannabis while maintaining some traditional boundaries.

Key aspects of MLB’s current cannabis approach:

No testing or penalties for major league players using marijuana
CBD products allowed if they contain less than 0.3% THC under federal transportation guidelines and meet league standards
Minor league players still face restrictions including potential fines and treatment requirements
Medical marijuana cards respected in states where legally obtained
Education programs about cannabis effects and legal considerations

Players increasingly view cannabis as a safer alternative to opioid pain management for chronic injuries. The sport’s demanding schedule creates ongoing pain management needs, and some players advocate for cannabis as part of comprehensive wellness programs rather than traditional pharmaceutical approaches.

The policy shift reflects changing medical understanding and societal acceptance. As more states legalize cannabis and research expands, MLB’s approach may continue evolving. The league’s current stance positions it ahead of other major sports in cannabis acceptance while maintaining focus on player health and performance rather than prohibition.

The Evolution Continues: What’s Next for MLB Drug Policy

Baseball’s drug policy continues evolving as new substances emerge and medical understanding advances. The sport’s approach has shifted from reactive crisis management to proactive health-focused policies that balance competitive integrity with player welfare and changing societal attitudes toward various substances.

Emerging challenges include designer drugs, genetic enhancement technologies, and therapeutic use exemptions for legitimate medical needs. The league works closely with testing laboratories to identify new performance-enhancing substances before they become widespread, learning from the steroid era’s delayed response.

The cannabis policy change signals a broader shift toward evidence-based drug policies rather than blanket prohibition. Future policies may increasingly distinguish between substances that enhance performance, those used for legitimate medical purposes, and recreational drugs that don’t provide competitive advantages.

Areas of ongoing policy development:

Therapeutic use exemptions for players with legitimate medical needs requiring controlled substances
Mental health medications and their interaction with performance and testing protocols
Recovery and regeneration aids that blur the line between legal supplements and performance enhancement
International policy coordination as MLB expands globally and players come from different regulatory environments

The sport’s relationship with performance enhancement reflects broader questions about human enhancement, medical ethics, and competitive fairness. As medical technology advances and societal attitudes shift, baseball’s policies will continue adapting to maintain competitive integrity while supporting player health and wellness.

Modern drug policy in baseball represents a maturation from the scandal-driven responses of previous decades. The focus has shifted toward comprehensive health management that acknowledges both the pressures players face and the legitimate medical needs that arise from professional athletics. This evolution positions the sport to handle future challenges more effectively while maintaining the integrity that fans expect from America’s pastime.

Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.

Note: Veriheal does not support illegally consuming therapeutic substances such as cannabis but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Ready to explore how cannabis for athletes might fit into your wellness routine? Veriheal connects you with qualified physicians who understand both cannabis medicine and athletic performance needs. Get started today to discuss whether medical cannabis could benefit your health and recovery goals.

Frequently Asked Questions

When did drug testing start in Major League Baseball?

Mandatory drug testing began in 2004, following voluntary survey testing in 2003 that revealed widespread steroid use among players.

What drugs are MLB players tested for?

Players face testing for performance-enhancing drugs, amphetamines, and other banned substances. Marijuana is no longer tested for major league players as of 2019.

How long are suspensions for steroid use in MLB?

First-time steroid violations result in 80-game suspensions, second violations bring 162-game suspensions, and third violations result in lifetime bans.

Can MLB players use CBD products?

Yes, players can use CBD products that contain less than 0.3% THC under FDA regulations for cannabis-derived products and meet league standards for purity and manufacturing.

What was the Pittsburgh drug trial?

The 1985 federal investigation exposed widespread cocaine use among MLB players, leading to testimony from 24 players and baseball’s first comprehensive drug policy.

Who holds the single-season home run record?

Barry Bonds holds the record with 73 home runs in 2001, though this achievement occurred during the steroid era and remains controversial.

Are minor league players subject to different drug rules?

Yes, minor league players still face marijuana testing and penalties, unlike major league players who are no longer tested for cannabis use.

Author, Share & Comments

Anthony DiMeo is a Southern New Jersey-based journalist and cannabis advocate whose work and advocacy have been featured in Leafly, DOPE Magazine, and the Philadelphia Inquirer. Hobbies include navigating interdimensional psychedelic energy vortexes and tennis.